StockClub

VYNE

VYNEVYNE Therapeutics Inc.$ --
VYNE Therapeutics Inc.

VYNE Therapeutics Inc.

VYNE

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
0M USD
YoY -57.4%
Operating Income
-4M USD
YoY +58.5%
Net Income
-4M USD
YoY +58.4%
EPS
-0.08$
YoY +58.1%

Revenue

$86,000
FY2024 Q2$296,000
$296,000
Q2
FY2024 Q3$417,000
$417,000
Q3
FY2024 Q4$501,000
$501,000
Q4
FY2025 Q1$202,000
$202,000
Q1
FY2025 Q2$271,000
$271,000
Q2
FY2025 Q3$440,000
$440,000
Q3
FY2025 Q4$570,000
$570,000
Q4
FY2026 Q1$86,000
$86,000
Q1
Actual
$-116,000 (-57.4%)

Net Income

$-3.6M
FY2024 Q2$-15.7M
$-15.7M
Q2
FY2024 Q3$-27.8M
$-27.8M
Q3
FY2024 Q4$-39.8M
$-39.8M
Q4
FY2025 Q1$-8.6M
$-8.6M
Q1
FY2025 Q2$-14.4M
$-14.4M
Q2
FY2025 Q3$-21.6M
$-21.6M
Q3
FY2025 Q4$-26.5M
$-26.5M
Q4
FY2026 Q1$-3.6M
$-3.6M
Q1
Actual
+$5M (+58.4%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$21M
Est:$21.4M
FY2020MISS
$21M
FY2021MISS
Actual:$931,000
Est:$17.3M
FY2021MISS
$931,000
FY2022BEAT
Actual:$477,000
Est:$366,667
FY2022BEAT
$477,000
FY2023MISS
Actual:$424,000
Est:$486,000
FY2023MISS
$424,000
FY2024MISS
Actual:$501,000
Est:$533,333
FY2024MISS
$501,000
FY2025MISS
Actual:$570,000
Est:$600,000
FY2025MISS
$570,000

Analyst Estimates